OAC
CNTB

OMERS Administration Corp’s Connect Biopharma Holdings CNTB Stock Holding History

OMERS Administration Corp’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-80,808
Closed -$228K – 1114
2025
Q4 		$228K Buy
+80,808
New +$172K ﹤0.01% 887

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

OMERS Administration Corp's CNTB Position: Q1 2026 in Review

OMERS Administration Corp sold out of Connect Biopharma Holdings (CNTB) in Q1 2026, closing a stake of 80,808 shares — an estimated $228K sold.

OMERS Administration Corp first reported a position in CNTB in Q4 2025 and held it in 1 quarter. The position peaked at $228K in Q4 2025. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • OMERS Administration Corp reported no remaining Connect Biopharma Holdings position as of Q1 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 80,808 Connect Biopharma Holdings shares in Q1 2026, an estimated $228K.
  • OMERS Administration Corp first reported a position in Connect Biopharma Holdings in Q4 2025 and held it in 1 quarter.
  • OMERS Administration Corp's Connect Biopharma Holdings position peaked at $228K in Q4 2025.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.